Trial Profile
A randomized phase IIb study comparing levetiracetam alone with lacosamide add-on for reduction of epileptic seizure after brain tumor surgery
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2020
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Levetiracetam (Primary) ; Fosphenytoin
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms CLEAR-EPI
- 06 Oct 2018 Status changed from not yet recruiting to recruiting.
- 03 Apr 2018 New trial record